A Safety Study of Pentoxifylline for the Treatment of Anemia

Summary

Chronic kidney disease (CKD) patients have increased levels of inflammation and oxidative stress, which in turn contribute to anemia and cardiovascular disease. Pentoxifylline is known to have anti-inflammatory and anti-oxidant properties, and has shown promise in improving the treatment of patients with anemia. This study will examine the use of pentoxifylline for the treatment of anemia in chronic kidney disease.

Timeline

Start

2010-08

Primary completion

2012-01

Completion

2012-01

Drugs

Indications